Rhelion Life Sciences Corp (RHEL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2021 | 03-2020 | 03-2019 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 31,185 | 1,963 | 0 |
| Marketable Securities | 1,596 | N/A | N/A |
| Receivables | 533 | 21 | 0 |
| Inventories | 438 | N/A | N/A |
| Other current assets | 0 | 1,804 | 0 |
| TOTAL | $33,875 | $3,967 | $0 |
| Non-Current Assets | |||
| PPE Net | 272 | N/A | N/A |
| Intangibles | 2,148 | N/A | N/A |
| TOTAL | $2,420 | $0 | $0 |
| Total Assets | $36,295 | $3,967 | $0 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | N/A | 87 | 1,042 |
| Other current liabilities | N/A | 3,609 | N/A |
| TOTAL | $1,125 | $4,586 | $2,143 |
| Non-Current Liabilities | |||
| Long Term Debt | 714 | N/A | N/A |
| Other Non-Current Liabilities | 0 | 526 | 526 |
| TOTAL | $1,116 | $526 | $526 |
| Total Liabilities | $2,240 | $5,112 | $2,669 |
| Shareholders' Equity | |||
| Common Shares | 31,221 | 4,017 | 4,017 |
| Retained earnings | -10,765 | -9,120 | -8,795 |
| Other shareholders' equity | 11,000 | 2,111 | 313 |
| TOTAL | $34,055 | $-1,144 | $-2,669 |
| Total Liabilities And Equity | $36,295 | $3,967 | $0 |